Interaction of the amyloid precursor protein with PTB domain-containing adaptors and their potential involvement in Alzheimer's disease

被引:0
|
作者
Zambrano, N [1 ]
Faraonio, R [1 ]
Mosca, R [1 ]
Longo, O [1 ]
Arcari, P [1 ]
Russo, T [1 ]
机构
[1] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy
来源
MEMORY AND EMOTION | 2002年 / 12卷
关键词
D O I
10.1142/9789812776563_0037
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Fe65 is a brain-abundant protein with the modular structure of a typical adaptor, containing three protein-protein interaction domains. Fe65 and the related proteins Fe65L1 and Fe65L2 interact with the cytosolic domain of the Alzheimer's P-amyloid precursor protein (APP), a membrane protein, from which the P-amyloid peptide (AD), is generated. Ligands for the other Fe65 protein-protein interaction domains have also been identified. Fe65 proteins are not the unique ligands of the APP cytodomain; other adapters, such as X11alpha and Dab-1, bind APP in a fashion similar to Fe65. Since the interaction of either Fe65 or X11alpha or Dab-1 with APP seem to be mutually exclusive, it is believed that each adaptor is able to recruit at the membrane level large macromolecular complexes involved in different cellular activities, such as the intracellular trafficking of proteins and vesicles. The molecular characterization of this system of interacting proteins is believed to be important for the understanding of the molecular mechanisms leading to AD pathogenesis, since overexpression in cultured cells of either Fe65 or X11 causes opposite effects on APP processing and AD generation.
引用
收藏
页码:440 / 444
页数:5
相关论文
共 50 条
  • [41] The amyloid precursor protein: a converging point in Alzheimer’s disease
    Alexandré Delport
    Raymond Hewer
    Molecular Neurobiology, 2022, 59 : 4501 - 4516
  • [42] Amyloid precursor protein, Alzheimer's disease, and Down's syndrome
    Koo, Edward H.
    Alzheimer: 100 Years and Beyond, 2006, : 197 - 199
  • [43] Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease
    Lahiri, DK
    Farlow, MR
    Hintz, N
    Utsuki, T
    Greig, NH
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 : 60 - 67
  • [44] Alzheimer's disease:: Physiological and pathogenetic role of the amyloid precursor protein (APP), its Aβ-amyloid domain and free Aβ-amyloid peptide
    Beyreuther, K
    Master, CL
    NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION, 2001, : 97 - 117
  • [45] Determining the Protein Stability of Alzheimer's Disease Protein, Amyloid Precursor Protein
    Delport, Alexandre
    Hewer, Raymond
    PROTEIN JOURNAL, 2019, 38 (04): : 419 - 424
  • [46] Determining the Protein Stability of Alzheimer’s Disease Protein, Amyloid Precursor Protein
    Alexandré Delport
    Raymond Hewer
    The Protein Journal, 2019, 38 : 419 - 424
  • [47] Structure of Alzheimer's disease amyloid precursor protein copper-binding domain at atomic resolution
    Kong, Geoffrey Kwai-Wai
    Adams, Julian J.
    Cappai, Roberto
    Parker, Michael W.
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2007, 63 : 819 - 824
  • [48] Implications of amyloid precursor protein and subsequent β-amyloid production to the pharmacotherapy of Alzheimer's disease
    Rojas-Fernandez, CH
    Chen, M
    Fernandez, HL
    PHARMACOTHERAPY, 2002, 22 (12): : 1547 - 1563
  • [49] The metabolism of the amyloid precursor protein of Alzheimer's disease and dietary zinc
    Whyte, S
    Jones, L
    Coulson, EJ
    Moir, RD
    Bush, AI
    Beyreuther, K
    Masters, CL
    ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, 1997, : 417 - 422
  • [50] Presenilins, β-amyloid precursor protein and the molecular basis of Alzheimer's disease
    Selkoe, DJ
    CLINICAL NEUROSCIENCE RESEARCH, 2001, 1 (1-2) : 91 - 103